Exploring the Ca2+ signaling and cytotoxicity induced by the alantolactone in breast cancer cells and its potential implications in treatment using the Ca2+ chelating agent BAPTA-AM. - Su CL; Chang PM; Liang WZ (Toxicology research, 2025)